Xencor (XNCR) Non-Current Deffered Revenue (2013 - 2024)
Xencor (XNCR) posted quarterly Non-Current Deffered Revenue of $94.1 million for Q3 2024, down 9.58% quarter-over-quarter from $104.1 million in Q2 2024.
Powered by 
Analysis
Xencor (XNCR) Non-Current Deffered Revenue (2013 - 2024) Analysis & Trends
Xencor (XNCR) has reported Non-Current Deffered Revenue for 8 consecutive years, with $94.1 million the latest figure, recorded in Q3 2024.
- In Q3 2024, Non-Current Deffered Revenue changed N/A year-over-year to $94.1 million; the TTM figure through Sep 2024 stood at $94.1 million (changed N/A YoY), while the FY2019 annual figure was $1.9 million, up 58.6% from the prior year.
- Non-Current Deffered Revenue fell to $94.1 million in Q3 2024 per XNCR's latest filing, from $104.1 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $104.1 million in Q2 2024 and bottomed at $94.1 million in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 220.40 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 147.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Xencor | 2.02 Bn | 1.65 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 94.11 Mn |
| Jun 30, 2024 | 104.08 Mn |
| Dec 31, 2019 | 1.93 Mn |
| Sep 30, 2019 | 2.60 Mn |
| Jun 30, 2019 | 3.30 Mn |
| Mar 31, 2019 | 3.90 Mn |
| Dec 31, 2018 | 1.20 Mn |
| Sep 30, 2018 | 1.29 Mn |
| Jun 30, 2018 | 1.12 Mn |
| Mar 31, 2018 | 1.18 Mn |
| Dec 31, 2017 | 1.09 Mn |
| Sep 30, 2017 | 6.19 Mn |
| Jun 30, 2017 | 6.75 Mn |
| Mar 31, 2017 | 7.32 Mn |
| Dec 31, 2016 | 7.93 Mn |
| Sep 30, 2016 | 8.61 Mn |
| Jun 30, 2016 | 9.31 Mn |
| Mar 31, 2016 | 476,000.00 |
| Dec 31, 2015 | 542,000.00 |
| Sep 30, 2015 | 931,000.00 |